Views & Analysis Building a better future for people with rare diseases in al... How has rare disease care changed over the last few years? And what might we expect from the next five?
News Former Seagen CEO Siegall pops up at new biotech Siegall resigned from Seagen last year amid claims of domestic abuse, though was not charged.
R&D Sponsored An inside guide to unlocking clinical research in the UK An inside guide to unlocking clinical research in the UK
